The potential of continuous processing methodologies to reduce variability while increasing efficiency, productivity and time-to-market are well proven in a range of industries—and has been proven to bring the same benefits to the pharmaceutical value chain. In this webinar, Dr. Malcolm Berry, recognized leader in developing continuous processes for small molecule active pharmaceutical ingredients (APIs) will discuss challenges with implementation, key observations, and Dr. Eric Edwards, CEO and Co-Founder of Phlow, will cover how continuous processing is helping Phlow Corp., a U.S.-based public benefit corporation to bring new levels of efficiency and quality to the organization’s contract development and manufacturing services, in turn helping pharmaceutical and biotech companies of all sizes reduce production costs, decrease development time, and lower their environmental impact.